Blood Clot Breakdown in Severe Infection and Injury
Part of Infections, Injuries & trauma clinical trials.
This trial studies how well the body's natural clot-busting system works in people with serious infections or major injuries. It may help doctors find better ways to treat these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the ICU with a serious infection or injury.
- Doctors expect you to survive and stay in the ICU for at least two more days.
- You are not on blood-thinning medications (like warfarin or clopidogrel).
- You are receiving full, active treatment in the ICU (not just comfort care).
- If you have a trauma injury, you need breathing support and may need a blood transfusion.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether giving fibrinogen early can improve outcomes for adults with serious trauma who are actively bleeding. The goal is to help blood clotting work better sooner and potentially reduce complications from uncontrolled bleeding.
This trial looks at two medicines (PCC and recombinant activated Factor VIIa) that help blood clot, to see which works better for trauma patients who need a lot of blood transfusions. If you have a severe injury and need many blood transfusions quickly, this study may help identify the best treatment.
This Phase 2 trial tests whether using a blood test that shows clotting strength and “clot breakdown time” can help guide treatment for people in the ICU with acute respiratory failure from infection. If you qualify, the team will use these blood results to decide on clot-related therapy and compare outcomes to standard care.
This study is testing a special blood test called ROTEM to see how well it can predict bleeding problems in ICU patients with sepsis or severe trauma. It may help doctors give the right treatment faster.
This trial tests giving a blood clotting medicine called fibrinogen to adults with severe bleeding from trauma before they reach the hospital. The goal is to see if it helps control bleeding and improve outcomes.
This study looks at how often sepsis leads to blood clotting issues in critically ill patients, and what happens to those patients. It aims to help doctors better understand and treat this complication.
Hear when a new Sepsis and Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.